Cancer cell lines, including HCC1806, NCI-N87, BxPC3, Calu3, and NCI-H23 (TROP2+), highly expressed TROP2, while NCI-H23 (parental) was TROP2-negative (Figure 3). This evidence concerns the gene TACSTD2 and cancer.